ClinicalTrials.gg
CompletedNCT06209242Updated Jan 17, 2024

Cast Immobilization Versus Percutaneous Pinning for Fracture of Radius in an Elderly Patient

An interventional study of Percutaneous pinning and Cast immobilization in Closed Fracture of Lower End of Radius, sponsored by Queen Savang Vadhana Memorial Hospital, Thailand. Completed at 1 site in Thailand. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2024-01-17.

Sponsored by Queen Savang Vadhana Memorial Hospital, Thailand · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 4 months after the study started (first participant enrolled Aug 2021, registered Dec 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Distal radius fractures, particularly in elderly individuals, are a common problem associated with increasing age and hormonal changes. The choice of treatment, such as cast immobilization or percutaneous pinning, plays a crucial role in achieving optimal functional outcomes and facilitating a return to normal activities. This study aimed to compare the radiological and clinical outcomes of cast immobilization and percutaneous pinning in elderly patients with distal radius fractures.

Read the detailed description

Background: Distal radius fractures, particularly in elderly individuals, are a common problem associated with increasing age and hormonal changes. The choice of treatment, such as cast immobilization or percutaneous pinning, plays a crucial role in achieving optimal functional outcomes and facilitating a return to normal activities. This study aimed to compare the radiological and clinical outcomes of cast immobilization and percutaneous pinning in elderly patients with distal radius fractures.

Methods: This prospective randomized controlled trial enrolled participants aged over 60 years with AO23-A2 or AO23-A3 distal radius fractures and no contraindications for local anesthesia. The participants were randomly assigned to either the cast immobilization or percutaneous pinning group. Follow-up was conducted for 3 months, during which radiological outcomes and clinical outcomes were assessed. Radiological parameters included radial angulation, while clinical outcomes were evaluated using the Disability of Arm, Shoulder, and Hand (DASH) score, range of motion, and grip strength. Additionally, data on complications and pain levels measured using the Visual Analog Scale (VAS) were collected for the percutaneous pinning group under local anesthesia.

02

Conditions studied

  • Closed Fracture of Lower End of Radius

Browse trials for

03

In context

Fractures, Closed

44 studies on the registry are indexed under Fractures, Closed; 4 are open to participants now.

This study's enrollment of 26 is below the median of 45 across 34 interventional studies indexed under Fractures, Closed.

Browse Fractures, Closed studies →

Lead sponsor

Queen Savang Vadhana Memorial Hospital, Thailand is the lead sponsor of 29 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged >60 years
  • primary distal end radius fracture type AO23-A2 or AO23-A3

Exclusion criteria

Exclusion Criteria:

  • multiple trauma
  • onset > 2 weeks
  • systemic diseases such as RA
  • user
  • for LA
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Cast immobilization

    Using cast immobilization with sugar tong and short arm splinting

    Procedure: Cast immobilization

  • Experimental
    Percutaneous pinning

    Using k-wire percutaneous pinning

    Procedure: Percutaneous pinning

Interventions

  • ProcedurePercutaneous pinning

    Using k- wire percutaneous pinning with local anesthesia with one-day surgery protocol

  • ProcedureCast immobilization

    Using sugar tong slab and then replace to short arm casting within 1 week

06

What researchers measure

Primary outcomes

  1. Radiological parameters

    Radial angulation, radial inclination, ulnar deviation, radial height

    Time frame: 1 wk , 4 wk , 3 months

Secondary outcomes

  1. DASH score

    Functional outcome

    Time frame: 1 month, 3 months

  2. Hand function

    Range of motion, grip strength

    Time frame: 1 month, 3 months

07

Study locations

1 site
  • Queen Savang Vadhana Memorial hospital
    Chon Buri, Sriracha 20110, Thailand
08

References and documents

Individual participant data

Plan to share: No — Data was save inform of excel, sheets and SPSS

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06209242
Lead sponsor
Queen Savang Vadhana Memorial Hospital, Thailand
Responsible party
Sponsor
First posted
Jan 17, 2024
Start date
Aug 1, 2021
Primary completion
Dec 1, 2023
Completion
Dec 1, 2023
Last update
Jan 17, 2024

Study contacts

Teerasit Punprasitwech, MD
principal investigator · QSMVH

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion